Effects of methimazole on the elimination of irinotecan

Abstract

To study the possible pharmacokinetic and pharmacodynamic interactions between irinotecan and methimazole. A patient treated for colorectal cancer with single agent irinotecan received methimazole co-medication for Graves’ disease. Irinotecan pharmacokinetics and side effects were followed during a total of four courses (two courses with and two courses… (More)
DOI: 10.1007/s00280-010-1414-x

3 Figures and Tables

Topics

  • Presentations referencing similar topics